70-90% of SMARCA4 alterations were homozygous in NSCLC subtypes including the most common subtype, lung adenocarcinoma, with 15-40% representing truncating alterations (Supplementary Fig. 1d–e). The gene discussed is SMARCA4; the disease is lung adenocarcinoma.